We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

261 hedge funds and large institutions have $1.46B invested in Pacira BioSciences in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 86 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

12% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 86

1% more funds holding

Funds holding: 258 → 261 (+3)

8% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 38

4% more call options, than puts

Call options by funds: $6.41M | Put options by funds: $6.14M

0.09% less ownership

Funds ownership: 102.18% → 102.08% (-0.09%)

23% less capital invested

Capital invested by funds: $1.88B → $1.46B (-$427M)

Holders
261
Holders Change
+3
Holders Change %
+1.16%
% of All Funds
4.14%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.08%
New
41
Increased
96
Reduced
86
Closed
38
Calls
$6.41M
Puts
$6.14M
Net Calls
+$275K
Net Calls Change
-$1M

Top Buyers

Rank Fund Capital Flow
1
Macquarie Group
Macquarie Group
Australia
+$33.7M
2
RCMNY
Rubric Capital Management (New York)
New York
+$16.6M
3
PM
Prosight Management
Texas
+$12M
4
AAP
Ardsley Advisory Partners
Connecticut
+$11.2M
5
CC
Clearline Capital
New York
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$26.2M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$25.8M
3
Invesco
Invesco
Georgia
-$16.9M
4
Jennison Associates
Jennison Associates
New York
-$12.4M
5
PCM
Portolan Capital Management
Massachusetts
-$8.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
101
Jane Street
New York
$1.09M -$1.65M -45,756 -56%
New York State Teachers Retirement System (NYSTRS)
102
New York State Teachers Retirement System (NYSTRS)
New York
$1.07M -$10.8K -300 -0.9%
JFG
103
Jefferies Financial Group
New York
$1.06M +$734K +20,351 +142%
CNAM
104
Campbell Newman Asset Management
Wisconsin
$1.06M -$21.8K -606 -2%
Voloridge Investment Management
105
Voloridge Investment Management
Florida
$1.06M +$1.24M +34,410 New
New York State Common Retirement Fund
106
New York State Common Retirement Fund
New York
$1.03M -$386K -10,720 -24%
Envestnet Asset Management
107
Envestnet Asset Management
Illinois
$1.03M -$28.1K -779 -2%
Barclays
108
Barclays
United Kingdom
$1.02M +$53.8K +1,493 +5%
DA
109
Duality Advisers
Florida
$1,000K +$189K +5,241 +19%
OF
110
Outfitter Financial
Maine
$991K +$3.96K +110 +0.3%
Los Angeles Capital Management
111
Los Angeles Capital Management
California
$990K +$5.01K +139 +0.4%
VHAM
112
Van Hulzen Asset Management
California
$971K +$384K +10,664 +51%
COPPSERS
113
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$952K -$755K -20,953 -40%
CIC
114
Cornercap Investment Counsel
Georgia
$951K +$1.12M +31,007 New
Royal Bank of Canada
115
Royal Bank of Canada
Ontario, Canada
$951K +$125K +3,459 +13%
American Century Companies
116
American Century Companies
Missouri
$928K +$333K +9,237 +44%
State of Tennessee, Department of Treasury
117
State of Tennessee, Department of Treasury
Tennessee
$923K – – –
SOADOR
118
State of Alaska Department of Revenue
Alaska
$887K -$48.4K -1,343 -4%
Wells Fargo
119
Wells Fargo
California
$871K -$448K -12,431 -30%
DekaBank Deutsche Girozentrale
120
DekaBank Deutsche Girozentrale
Germany
$845K – – –
IMRF
121
Illinois Municipal Retirement Fund
Illinois
$809K +$951K +26,373 New
VOYA Investment Management
122
VOYA Investment Management
Georgia
$804K +$7.07K +196 +0.8%
HSA
123
Hussman Strategic Advisors
Maryland
$798K – – –
CM
124
Caption Management
Oklahoma
$798K +$245K +6,800 +35%
PCM
125
Polaris Capital Management
Massachusetts
$776K – – –
3 4
5
6 7

PCRX Hedge Fund Activity: Q3 2023 in Review

261 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2023, worth a combined $1.46B — down 23% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new PCRX positions and 38 closed out — a net gain of 3 holders — while 96 added to existing stakes and 86 trimmed.

The largest buyer was Macquarie Group, adding an estimated $33.7M. The largest seller was Citadel Advisors, cutting an estimated $26.2M.

  • 261 institutional investors held Pacira BioSciences (PCRX) as of Q3 2023, up from 258 in Q2 2023.
  • Funds reported $1.46B of Pacira BioSciences stock for Q3 2023, down 23% quarter-over-quarter.
  • 41 funds opened new Pacira BioSciences positions in Q3 2023 and 38 closed out, a net change of +3 holders.
  • The largest Pacira BioSciences buyer in Q3 2023 was Macquarie Group, an estimated $33.7M added.
  • The largest Pacira BioSciences seller in Q3 2023 was Citadel Advisors, an estimated $26.2M sold.

Based on aggregated 13F filings for Q3 2023.